Foster City, CA, United States of America

Anita A Mathias

This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anita A Mathias. Retrieved from https://idiyas.com/inventor/anita-a-mathias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anita A Mathias: Innovator in Pharmaceutical Composition

Introduction

Anita A Mathias is a notable inventor based in Foster City, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in improving the processability of pharmaceutical agents.

Latest Patents

Anita holds a patent for the "Use of solid carrier particles to improve the processability of a pharmaceutical agent." This invention provides a composition that includes a compound of formula (I) or a pharmaceutically acceptable salt thereof, along with a plurality of solid carrier particles. The methods outlined in her patent aim to inhibit the activity of cytochrome P-450, showcasing her innovative approach to pharmaceutical development. She has 1 patent to her name.

Career Highlights

Anita is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on innovative therapies. Her work at Gilead has allowed her to contribute to advancements in the pharmaceutical industry.

Collaborations

Anita has collaborated with several talented individuals, including Joanna M Koziara and Mark Michael Menning, enhancing her research and development efforts.

Conclusion

Anita A Mathias is a pioneering inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. Her innovative spirit and dedication to improving drug processability are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…